High-priced specialty drugs dominated the market for new drugs in 2015 and 2016, both in Canada and internationally, continuing a trend that has been evident since 2009.
Marketers associated with one pharmacy recruited dentists, physicians, nurse practitioners and others to writing bogus prescriptions to patients they never examined
The reliability of a new guideline for the management of chronic hepatitis C is questionable, given the financial conflicts of interest documented by its authors
